1. Home
  2. PMVP vs ICCM Comparison

PMVP vs ICCM Comparison

Compare PMVP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • ICCM
  • Stock Information
  • Founded
  • PMVP 2013
  • ICCM 2006
  • Country
  • PMVP United States
  • ICCM Israel
  • Employees
  • PMVP N/A
  • ICCM N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • ICCM
  • Sector
  • PMVP Health Care
  • ICCM
  • Exchange
  • PMVP Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • PMVP 71.9M
  • ICCM 75.8M
  • IPO Year
  • PMVP 2020
  • ICCM N/A
  • Fundamental
  • Price
  • PMVP $1.41
  • ICCM $1.41
  • Analyst Decision
  • PMVP Strong Buy
  • ICCM Strong Buy
  • Analyst Count
  • PMVP 3
  • ICCM 2
  • Target Price
  • PMVP $5.33
  • ICCM $2.70
  • AVG Volume (30 Days)
  • PMVP 108.7K
  • ICCM 379.2K
  • Earning Date
  • PMVP 03-07-2025
  • ICCM 04-02-2025
  • Dividend Yield
  • PMVP N/A
  • ICCM N/A
  • EPS Growth
  • PMVP N/A
  • ICCM N/A
  • EPS
  • PMVP N/A
  • ICCM N/A
  • Revenue
  • PMVP N/A
  • ICCM $3,671,000.00
  • Revenue This Year
  • PMVP N/A
  • ICCM $10.03
  • Revenue Next Year
  • PMVP N/A
  • ICCM $62.68
  • P/E Ratio
  • PMVP N/A
  • ICCM N/A
  • Revenue Growth
  • PMVP N/A
  • ICCM 26.02
  • 52 Week Low
  • PMVP $1.32
  • ICCM $0.48
  • 52 Week High
  • PMVP $2.26
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 47.85
  • ICCM 60.09
  • Support Level
  • PMVP $1.36
  • ICCM $1.22
  • Resistance Level
  • PMVP $1.47
  • ICCM $1.66
  • Average True Range (ATR)
  • PMVP 0.05
  • ICCM 0.09
  • MACD
  • PMVP 0.00
  • ICCM 0.01
  • Stochastic Oscillator
  • PMVP 52.17
  • ICCM 43.18

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: